| Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity | Proceedings of the National Academy of Sciences of the United States of America | 2013 | 2.5K |
| Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics | Nature Reviews Gastroenterology and Hepatology | 2017 | 2K |
| Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology | Gut | 2016 | 938 |
| A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice | Nature Medicine | 2017 | 896 |
| Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study | Nature Medicine | 2019 | 650 |
| Human gut microbiome: hopes, threats and promises | Gut | 2018 | 599 |
| Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling | Cell Metabolism | 2015 | 562 |
| Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice | Scientific Reports | 2015 | 464 |
| Next-Generation Beneficial Microbes: The Case of | Frontiers in Microbiology | 2017 | 459 |
| Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity | Proceedings of the National Academy of Sciences of the United States of America | 2014 | 455 |
| Human Intestinal Barrier Function in Health and Disease | Clinical and Translational Gastroenterology | 2016 | 396 |
| Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity | ISME Journal | 2014 | 376 |
| Diabetes, obesity and gut microbiota | Bailliere's Best Practice and Research in Clinical Gastroenterology | 2013 | 360 |
| Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3 | Molecular and Cellular Biology | 2000 | 284 |
| Gut microbiome and liver diseases | Gut | 2016 | 252 |
| Prebiotics: why definitions matter | Current Opinion in Biotechnology | 2016 | 245 |
| Homeostasis of the gut barrier and potential biomarkers | American Journal of Physiology - Renal Physiology | 2017 | 240 |
| Gut microbiota, enteroendocrine functions and metabolism | Current Opinion in Pharmacology | 2013 | 238 |
| Microbial modulation of energy availability in the colon regulates intestinal transit | Cell Host and Microbe | 2013 | 232 |
| Can probiotics modulate human disease by impacting intestinal barrier function? | British Journal of Nutrition | 2017 | 218 |
| Andean potato cultivars (Solanum tuberosum L.) as a source of antioxidant and mineral micronutrients | Journal of Agricultural and Food Chemistry | 2007 | 207 |
| Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer | Cell | 2018 | 205 |
| Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics | Beneficial Microbes | 2014 | 193 |
| Endocannabinoids--at the crossroads between the gut microbiota and host metabolism | Nature Reviews Endocrinology | 2016 | 191 |
| Microbial regulation of organismal energy homeostasis | Nature Metabolism | 2019 | 186 |
